Company Filing History:
1 out of 2 
1 out of 243 
Years Active: 2020
Title: Innovations in Lung Cancer Diagnosis by Ganepola A Ganepola
Introduction
Ganepola A Ganepola is an accomplished inventor based in Hillsdale, NJ (US). He has made significant contributions to the field of medical diagnostics, particularly in the area of lung cancer. His innovative approach aims to enhance the accuracy of lung cancer screening and diagnosis.
Latest Patents
Ganepola holds a patent for a method and systems for lung cancer diagnosis. This invention relates to high-risk screening, diagnosis, prognosis, and surveillance of lung cancer. The method involves obtaining a first expression level of the AKAP4 gene from a population of cells in the blood of a test subject. By comparing this expression level with a predetermined reference value, the method can help diagnose or evaluate the risk of lung cancer, specifically non-small cell lung cancer (NSCLC).
Career Highlights
Throughout his career, Ganepola has worked with notable organizations such as Valley Health System and The Wistar Institute of Anatomy & Biology. His experience in these institutions has contributed to his expertise in medical research and diagnostics.
Collaborations
Ganepola has collaborated with professionals like Kiranmai Gumireddy and Qihong Huang. These partnerships have likely enriched his research and development efforts in lung cancer diagnostics.
Conclusion
Ganepola A Ganepola's innovative methods for lung cancer diagnosis represent a significant advancement in medical technology. His work has the potential to improve early detection and treatment outcomes for patients at risk of lung cancer.